Kristin A. Cassidy | Psychiatrist.com

Original Research

Aripiprazole Therapy in 20 Older Adults With Bipolar Disorder: A 12-Week, Open-Label Trial

Original Research

Customized Adherence Enhancement for Bipolar Disorder

Treatment nonadherence is bipolar disorder ranges from 20% to 60%. Read this article to learn how customized adherence enhancement (CAE)—a brief, bipolar disorder-specific approach that targets individual adherence barriers—compared...

Original Research

Prospective Trial of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic Medication in Homeless or Recently Homeless Individuals With Schizophrenia or Schizoaffective Disorder

Original Research

Long-Acting Injectable Antipsychotic Plus Customized Adherence Enhancement

Medication adherence is often difficult in bipolar patients. This trial combined a behavioral customized adherence enhancement approach with long-acting injectable antipsychotics and assessed effects on adherence, symptoms, and functional...